Review



cxcl1 proteintech  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Proteintech cxcl1 proteintech
    Cxcl1 Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 75 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm41548046-54-56-57?v=Proteintech
    Average 94 stars, based on 75 article reviews
    cxcl1 proteintech - by Bioz Stars, 2026-08
    94/100 stars

    Images



    Similar Products

    94
    Proteintech cxcl1 proteintech
    Cxcl1 Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm41548046-54-56-57?v=Proteintech
    Average 94 stars, based on 1 article reviews
    cxcl1 proteintech - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    93
    Proteintech dcp00 human cxcl1 elisa kit proteintech
    Dcp00 Human Cxcl1 Elisa Kit Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm41202806-260-135-140?v=Proteintech
    Average 93 stars, based on 1 article reviews
    dcp00 human cxcl1 elisa kit proteintech - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Proteintech mouse cxcl1 elisa kit proteintech cat
    Mouse Cxcl1 Elisa Kit Proteintech Cat, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm40441145-276-17-21?v=Proteintech
    Average 93 stars, based on 1 article reviews
    mouse cxcl1 elisa kit proteintech cat - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Proteintech q712 mouse cxcl1 elisa kit proteintech group
    Q712 Mouse Cxcl1 Elisa Kit Proteintech Group, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm39630582-216-182-187?v=Proteintech
    Average 93 stars, based on 1 article reviews
    q712 mouse cxcl1 elisa kit proteintech group - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    94
    Proteintech antibody rabbit cxcl1 12335 1 ap 1 50 proteintech group
    Antibody Rabbit Cxcl1 12335 1 Ap 1 50 Proteintech Group, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm38943679-77-15-20?v=Proteintech
    Average 94 stars, based on 1 article reviews
    antibody rabbit cxcl1 12335 1 ap 1 50 proteintech group - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    93
    Proteintech mouse cxcl1 elisa kit proteintech
    Mouse Cxcl1 Elisa Kit Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm38642552-245-55-59?v=Proteintech
    Average 93 stars, based on 1 article reviews
    mouse cxcl1 elisa kit proteintech - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    93
    Proteintech gsh caa 440 1 cxcl1 elisa kit proteintech
    Figure 4. <t>CXCL1</t> promotes migration and activation of fibroblasts via the CXCR2-STAT3 pathway (A) Western blot analysis of myCAF- and iCAF-related markers in fibroblasts incubated with CM from CXCL1-knockdown ESCC cells. (B) Quantification of migration in (Figure S5B) (n = 3 biological replicates). (C) Western blot analysis of myCAF- and iCAF-related markers in fibroblasts treated with indicated concentration of rCXCL1 proteins for 24 h. (D) Representative images of fibroblasts migration caused by indicated concentration of rCXCL1 proteins. Scale bar, 100 mm. (E) Quantification of migration in (D) (n = 3 biological replicates). (F) Western blot analysis of CAF markers in fibroblasts pre-treated with SB-265610 for 6 h and then treated by CM of KYSE510 for 18 h. KYSE510 cells were treated with Col1 or not. (G) Western blot analysis of CAF markers in fibroblasts pre-treated with SB-265610 for 6 h and then treated by rCXCL1 for 18 h. For all panels, data are presented as mean ± SD. **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. Each assay for western blot had three biological repeats, and the quantification results are presented below each band. See also Figure S5.
    Gsh Caa 440 1 Cxcl1 Elisa Kit Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cxcl1+proteintech/pm37851572-506-122-126?v=Proteintech
    Average 93 stars, based on 1 article reviews
    gsh caa 440 1 cxcl1 elisa kit proteintech - by Bioz Stars, 2026-08
    93/100 stars
      Buy from Supplier

    Image Search Results


    Figure 4. CXCL1 promotes migration and activation of fibroblasts via the CXCR2-STAT3 pathway (A) Western blot analysis of myCAF- and iCAF-related markers in fibroblasts incubated with CM from CXCL1-knockdown ESCC cells. (B) Quantification of migration in (Figure S5B) (n = 3 biological replicates). (C) Western blot analysis of myCAF- and iCAF-related markers in fibroblasts treated with indicated concentration of rCXCL1 proteins for 24 h. (D) Representative images of fibroblasts migration caused by indicated concentration of rCXCL1 proteins. Scale bar, 100 mm. (E) Quantification of migration in (D) (n = 3 biological replicates). (F) Western blot analysis of CAF markers in fibroblasts pre-treated with SB-265610 for 6 h and then treated by CM of KYSE510 for 18 h. KYSE510 cells were treated with Col1 or not. (G) Western blot analysis of CAF markers in fibroblasts pre-treated with SB-265610 for 6 h and then treated by rCXCL1 for 18 h. For all panels, data are presented as mean ± SD. **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. Each assay for western blot had three biological repeats, and the quantification results are presented below each band. See also Figure S5.

    Journal: Cell reports

    Article Title: Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer.

    doi: 10.1016/j.celrep.2023.113270

    Figure Lengend Snippet: Figure 4. CXCL1 promotes migration and activation of fibroblasts via the CXCR2-STAT3 pathway (A) Western blot analysis of myCAF- and iCAF-related markers in fibroblasts incubated with CM from CXCL1-knockdown ESCC cells. (B) Quantification of migration in (Figure S5B) (n = 3 biological replicates). (C) Western blot analysis of myCAF- and iCAF-related markers in fibroblasts treated with indicated concentration of rCXCL1 proteins for 24 h. (D) Representative images of fibroblasts migration caused by indicated concentration of rCXCL1 proteins. Scale bar, 100 mm. (E) Quantification of migration in (D) (n = 3 biological replicates). (F) Western blot analysis of CAF markers in fibroblasts pre-treated with SB-265610 for 6 h and then treated by CM of KYSE510 for 18 h. KYSE510 cells were treated with Col1 or not. (G) Western blot analysis of CAF markers in fibroblasts pre-treated with SB-265610 for 6 h and then treated by rCXCL1 for 18 h. For all panels, data are presented as mean ± SD. **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. Each assay for western blot had three biological repeats, and the quantification results are presented below each band. See also Figure S5.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Fetal Bovine Serum Cell Technologies Cat# 30070 DMEM Corning Cat# 10-013-CV Advanced DMEM/F12 Gibco Cat# 12634028 Puromycin Gibco Cat# A1113803 Lipofectamine 2000 Invitrogen Cat# 11668027 Collagenase I Gibco Cat# 17100017 Collagenase IV Gibco Cat# 17104019 Hyaluronidase Sigma-Aldrich Cat# H1115000 EDHB Sigma-Aldrich Cat# E24859 MK-2206 MCE Cat# HY-108232 SB-265610 MCE Cat# HY-50688 Human recombinant CXCL1 MCE Cat# HY-P70508 Rat tail collagen type 1 Solarbio Cat# C8062 Critical commercial assays RNA-Quick Purification Kit ES Science Cat# RN001 TB Green Premix Ex TaqTMII (Tli RNaseH Plus) TaKaRa Cat# RR820A Masson’s Trichrome Stain Kit Solarbio Cat# G1340 Meilunbio FGSuper Sensitive ECL Luminescence Reagent Meilunbio Cat# MA0186-1 PierceTM Rapid Gold BCA Thermo Fisher Scientific Cat# A53226 Human Cytokine Array GS440 Raybiotech Cat# GSH-CAA-440-1 CXCL1 ELISA Kit Proteintech Cat# KE00133 Opal 5-Color Manual IHC Kit PANOVUE Cat# 10144100100 NF-kB Activation Nuclear Translocation Assay Kit Beyotime Cat# SN368 Deposited data ESCC WES and RNA-seq data of 19 PDX donors This paper GSA-Human: HRA004329 Single-cell RNA-seq raw data of 6 PDXmice This paper GSA: https://ngdc.cncb.ac.cn/gsa/browse/ CRA010501 Experimental models: Cell lines KYSE450 Dr. Y. Shimada JCRB1430 KYSE510 Dr. Y. Shimada JCRB1436 NIH/3T3 ATCC CRL-1658 Human derived esophagus normal fibroblast (NF) This paper N/A PDX-derived primary tumor cells (PDC) This paper N/A Experimental models: Organisms/strains NSG mouse IDMO N/A Oligonucleotides shRNA targeting sequences, see Table S3 JTSBIO Co., Ltd N/A siRNA, see Table S3 JTSBIO Co., Ltd N/A qRT-PCR primers, see Table S4 Tsingke Biotechnology N/A Software and algorithms R 4.2.2 R Core Team https://www.R-project.org/ Cell Ranger 6.0.2 10x Genomics https://10xgenomics.com/ Seurat (version 4.3.0) Hao et al.46 https://github.com/satijalab/seurat (Continued on next page) 18 Cell Reports 42, 113270, October 31, 2023

    Techniques: Migration, Activation Assay, Western Blot, Incubation, Knockdown, Concentration Assay, Two Tailed Test

    Figure 5. CXCL1 affects radiosensitivity in vivo (A) Tumor growth curves and excised tumor images of control and CXCL1-knockdown tumors with or without IR treatment (n = 4 or 5 per group). TGI, percentage of tumor growth inhibition. (B) Representative mIF images of CXCL1, KRT6A, and aSMA in control and CXCL1-knockdown tumors without IR. Scale bar, 100 mm. (C and D) Quantification of CXCL1- and aSMA-positive area (n = 4 or 5 per group). (E) Tumor growth curves and excised tumor images of vector and CXCL1 overexpression tumors with or without IR treatment. Data are presented as mean ± SD (n = 5 per group). (F) Representative mIF images of CXCL1, KRT6A, and aSMA in control (vector) and CXCL1 overexpression (OE) tumors without IR. Scale bar, 100 mm. (G and H) Quantification of CXCL1- and aSMA-positive area (n = 5 per group). For all panels, data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. See also Figure S5.

    Journal: Cell reports

    Article Title: Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer.

    doi: 10.1016/j.celrep.2023.113270

    Figure Lengend Snippet: Figure 5. CXCL1 affects radiosensitivity in vivo (A) Tumor growth curves and excised tumor images of control and CXCL1-knockdown tumors with or without IR treatment (n = 4 or 5 per group). TGI, percentage of tumor growth inhibition. (B) Representative mIF images of CXCL1, KRT6A, and aSMA in control and CXCL1-knockdown tumors without IR. Scale bar, 100 mm. (C and D) Quantification of CXCL1- and aSMA-positive area (n = 4 or 5 per group). (E) Tumor growth curves and excised tumor images of vector and CXCL1 overexpression tumors with or without IR treatment. Data are presented as mean ± SD (n = 5 per group). (F) Representative mIF images of CXCL1, KRT6A, and aSMA in control (vector) and CXCL1 overexpression (OE) tumors without IR. Scale bar, 100 mm. (G and H) Quantification of CXCL1- and aSMA-positive area (n = 5 per group). For all panels, data are presented as mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. See also Figure S5.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Fetal Bovine Serum Cell Technologies Cat# 30070 DMEM Corning Cat# 10-013-CV Advanced DMEM/F12 Gibco Cat# 12634028 Puromycin Gibco Cat# A1113803 Lipofectamine 2000 Invitrogen Cat# 11668027 Collagenase I Gibco Cat# 17100017 Collagenase IV Gibco Cat# 17104019 Hyaluronidase Sigma-Aldrich Cat# H1115000 EDHB Sigma-Aldrich Cat# E24859 MK-2206 MCE Cat# HY-108232 SB-265610 MCE Cat# HY-50688 Human recombinant CXCL1 MCE Cat# HY-P70508 Rat tail collagen type 1 Solarbio Cat# C8062 Critical commercial assays RNA-Quick Purification Kit ES Science Cat# RN001 TB Green Premix Ex TaqTMII (Tli RNaseH Plus) TaKaRa Cat# RR820A Masson’s Trichrome Stain Kit Solarbio Cat# G1340 Meilunbio FGSuper Sensitive ECL Luminescence Reagent Meilunbio Cat# MA0186-1 PierceTM Rapid Gold BCA Thermo Fisher Scientific Cat# A53226 Human Cytokine Array GS440 Raybiotech Cat# GSH-CAA-440-1 CXCL1 ELISA Kit Proteintech Cat# KE00133 Opal 5-Color Manual IHC Kit PANOVUE Cat# 10144100100 NF-kB Activation Nuclear Translocation Assay Kit Beyotime Cat# SN368 Deposited data ESCC WES and RNA-seq data of 19 PDX donors This paper GSA-Human: HRA004329 Single-cell RNA-seq raw data of 6 PDXmice This paper GSA: https://ngdc.cncb.ac.cn/gsa/browse/ CRA010501 Experimental models: Cell lines KYSE450 Dr. Y. Shimada JCRB1430 KYSE510 Dr. Y. Shimada JCRB1436 NIH/3T3 ATCC CRL-1658 Human derived esophagus normal fibroblast (NF) This paper N/A PDX-derived primary tumor cells (PDC) This paper N/A Experimental models: Organisms/strains NSG mouse IDMO N/A Oligonucleotides shRNA targeting sequences, see Table S3 JTSBIO Co., Ltd N/A siRNA, see Table S3 JTSBIO Co., Ltd N/A qRT-PCR primers, see Table S4 Tsingke Biotechnology N/A Software and algorithms R 4.2.2 R Core Team https://www.R-project.org/ Cell Ranger 6.0.2 10x Genomics https://10xgenomics.com/ Seurat (version 4.3.0) Hao et al.46 https://github.com/satijalab/seurat (Continued on next page) 18 Cell Reports 42, 113270, October 31, 2023

    Techniques: In Vivo, Control, Knockdown, Inhibition, Plasmid Preparation, Over Expression, Two Tailed Test

    Figure 7. Col1 treatment promotes the secretion of CXCL1 in ESCC cells via NF-kB pathway (A) TRRUST enrichment analysis of elevated cytokines in Col1-treated KYSE450 cells. (B) qRT-PCR analysis of CXCL1 in ESCC cells treated with Col1 and RELA knockdown. The expression level was normalized to GAPDH (n = 3 biological rep- licates). (C) Western blot analysis of NF-kB phosphorylation in ESCC cells added to Col1-coated and uncoated plates for 24 h. (D) Representative immunofluorescence images of the activation and translocation of NF-kB P65 by Col1 treatment. KYSE450 cells were added to Col1-coated and uncoated plates for 24 h and then immunostained with NF-kB P65 antibody, followed by Cy3-conjugated secondary antibody (red) and DAPI (blue). White arrows indicate NF-kB P65 translocation in cells. Scale bar, 100 mm. (E) Quantification of the percentage of NF-kB P65 activated and translocated KYSE450 cells in (D) (n = 6 biological replicates). (F) Western blot analysis shows that the Akt inhibitor MK-2206 abrogated the phosphorylation of P65 and the increase of CXCL1 promoted by Col1 treatment. For all panels, data are presented as mean ± SD. **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. Each assay for western blot had three biological repeats, and the quantification results are presented below each band. See also Figure S7.

    Journal: Cell reports

    Article Title: Collagen 1-mediated CXCL1 secretion in tumor cells activates fibroblasts to promote radioresistance of esophageal cancer.

    doi: 10.1016/j.celrep.2023.113270

    Figure Lengend Snippet: Figure 7. Col1 treatment promotes the secretion of CXCL1 in ESCC cells via NF-kB pathway (A) TRRUST enrichment analysis of elevated cytokines in Col1-treated KYSE450 cells. (B) qRT-PCR analysis of CXCL1 in ESCC cells treated with Col1 and RELA knockdown. The expression level was normalized to GAPDH (n = 3 biological rep- licates). (C) Western blot analysis of NF-kB phosphorylation in ESCC cells added to Col1-coated and uncoated plates for 24 h. (D) Representative immunofluorescence images of the activation and translocation of NF-kB P65 by Col1 treatment. KYSE450 cells were added to Col1-coated and uncoated plates for 24 h and then immunostained with NF-kB P65 antibody, followed by Cy3-conjugated secondary antibody (red) and DAPI (blue). White arrows indicate NF-kB P65 translocation in cells. Scale bar, 100 mm. (E) Quantification of the percentage of NF-kB P65 activated and translocated KYSE450 cells in (D) (n = 6 biological replicates). (F) Western blot analysis shows that the Akt inhibitor MK-2206 abrogated the phosphorylation of P65 and the increase of CXCL1 promoted by Col1 treatment. For all panels, data are presented as mean ± SD. **p < 0.01, ***p < 0.001, and ****p < 0.0001, as determined using two-tailed Student’s t test. Each assay for western blot had three biological repeats, and the quantification results are presented below each band. See also Figure S7.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Fetal Bovine Serum Cell Technologies Cat# 30070 DMEM Corning Cat# 10-013-CV Advanced DMEM/F12 Gibco Cat# 12634028 Puromycin Gibco Cat# A1113803 Lipofectamine 2000 Invitrogen Cat# 11668027 Collagenase I Gibco Cat# 17100017 Collagenase IV Gibco Cat# 17104019 Hyaluronidase Sigma-Aldrich Cat# H1115000 EDHB Sigma-Aldrich Cat# E24859 MK-2206 MCE Cat# HY-108232 SB-265610 MCE Cat# HY-50688 Human recombinant CXCL1 MCE Cat# HY-P70508 Rat tail collagen type 1 Solarbio Cat# C8062 Critical commercial assays RNA-Quick Purification Kit ES Science Cat# RN001 TB Green Premix Ex TaqTMII (Tli RNaseH Plus) TaKaRa Cat# RR820A Masson’s Trichrome Stain Kit Solarbio Cat# G1340 Meilunbio FGSuper Sensitive ECL Luminescence Reagent Meilunbio Cat# MA0186-1 PierceTM Rapid Gold BCA Thermo Fisher Scientific Cat# A53226 Human Cytokine Array GS440 Raybiotech Cat# GSH-CAA-440-1 CXCL1 ELISA Kit Proteintech Cat# KE00133 Opal 5-Color Manual IHC Kit PANOVUE Cat# 10144100100 NF-kB Activation Nuclear Translocation Assay Kit Beyotime Cat# SN368 Deposited data ESCC WES and RNA-seq data of 19 PDX donors This paper GSA-Human: HRA004329 Single-cell RNA-seq raw data of 6 PDXmice This paper GSA: https://ngdc.cncb.ac.cn/gsa/browse/ CRA010501 Experimental models: Cell lines KYSE450 Dr. Y. Shimada JCRB1430 KYSE510 Dr. Y. Shimada JCRB1436 NIH/3T3 ATCC CRL-1658 Human derived esophagus normal fibroblast (NF) This paper N/A PDX-derived primary tumor cells (PDC) This paper N/A Experimental models: Organisms/strains NSG mouse IDMO N/A Oligonucleotides shRNA targeting sequences, see Table S3 JTSBIO Co., Ltd N/A siRNA, see Table S3 JTSBIO Co., Ltd N/A qRT-PCR primers, see Table S4 Tsingke Biotechnology N/A Software and algorithms R 4.2.2 R Core Team https://www.R-project.org/ Cell Ranger 6.0.2 10x Genomics https://10xgenomics.com/ Seurat (version 4.3.0) Hao et al.46 https://github.com/satijalab/seurat (Continued on next page) 18 Cell Reports 42, 113270, October 31, 2023

    Techniques: Quantitative RT-PCR, Knockdown, Expressing, Western Blot, Phospho-proteomics, Activation Assay, Translocation Assay, Two Tailed Test